Biblioteca Humberto Rosselli Quijano
Información del autor
Autor Jennifer B. Dwyer |
Documentos disponibles escritos por este autor (2)
Refinar búsquedaEfficacy of intravenous ketamine in adolescent treatment-resistant depression / Jennifer B. Dwyer en The American Journal of Psychiatry, Año 2021 - Vol. 178 - No.4 (Abril)
Título : Efficacy of intravenous ketamine in adolescent treatment-resistant depression : a randomized midazolam-controlled trial Tipo de documento: texto impreso Autores: Jennifer B. Dwyer, Autor ; Angeli Landeros Weisenberger, Autor ; Jessica A. Johnson, Autor Fecha de publicación: 2021 Artículo en la página: pp. 352-362 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Trastornos depresivos, Trastorno depresivo mayor, Psiquiatría de niños y adolescentes, Ketamina, Esketamina Resumen: Adolescent depression is prevalent and is associated with significant morbidity and mortality. Although intravenous ketamine has shown efficacy in adult treatment-resistant depression, its efficacy in pediatric populations is unknown. The authors conducted an active-placebo-controlled study of ketamine’s safety and efficacy in adolescents. Link: ./index.php?lvl=notice_display&id=26888
in The American Journal of Psychiatry > Año 2021 - Vol. 178 - No.4 (Abril) . - pp. 352-362[artículo] Efficacy of intravenous ketamine in adolescent treatment-resistant depression : a randomized midazolam-controlled trial [texto impreso] / Jennifer B. Dwyer, Autor ; Angeli Landeros Weisenberger, Autor ; Jessica A. Johnson, Autor . - 2021 . - pp. 352-362.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in The American Journal of Psychiatry > Año 2021 - Vol. 178 - No.4 (Abril) . - pp. 352-362
Palabras clave: Trastornos depresivos, Trastorno depresivo mayor, Psiquiatría de niños y adolescentes, Ketamina, Esketamina Resumen: Adolescent depression is prevalent and is associated with significant morbidity and mortality. Although intravenous ketamine has shown efficacy in adult treatment-resistant depression, its efficacy in pediatric populations is unknown. The authors conducted an active-placebo-controlled study of ketamine’s safety and efficacy in adolescents. Link: ./index.php?lvl=notice_display&id=26888
Título : Hormonal treatments for major depressive disorder : state of the art Tipo de documento: texto impreso Autores: Jennifer B. Dwyer, Autor ; Awais Aftab, Autor ; Rajiv Radhakrishnan, Autor Fecha de publicación: 2021 Artículo en la página: pp. 686-705 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antidepresivos, Neuroendocrinología Resumen: Major depressive disorder is a common psychiatric disorder associated with marked suffering, morbidity, mortality, and cost. The World Health Organization projects that by 2030, major depression will be the leading cause of disease burden worldwide. While numerous treatments for major depression exist, many patients do not respond adequately to traditional antidepressants. Link: ./index.php?lvl=notice_display&id=25875
in The American Journal of Psychiatry > Año 2020 - Vol. 177 - No.8 (Agosto) . - pp. 686-705[artículo] Hormonal treatments for major depressive disorder : state of the art [texto impreso] / Jennifer B. Dwyer, Autor ; Awais Aftab, Autor ; Rajiv Radhakrishnan, Autor . - 2021 . - pp. 686-705.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in The American Journal of Psychiatry > Año 2020 - Vol. 177 - No.8 (Agosto) . - pp. 686-705
Palabras clave: Antidepresivos, Neuroendocrinología Resumen: Major depressive disorder is a common psychiatric disorder associated with marked suffering, morbidity, mortality, and cost. The World Health Organization projects that by 2030, major depression will be the leading cause of disease burden worldwide. While numerous treatments for major depression exist, many patients do not respond adequately to traditional antidepressants. Link: ./index.php?lvl=notice_display&id=25875
